Previous 10 | Next 10 |
2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...
2024-05-10 09:45:00 ET It's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks that still look worth buying and holding onto for a while. Some corporations are condemned to deliver subpar finan...
2024-05-10 07:00:00 ET Summary High-yield dividend investing is a popular retirement strategy for its steady income, lower volatility, and potential to outperform the market. JPMorgan Equity Premium Income ETF offers an 8% yield but lacks dividend growth. Over a standard retiremen...
2024-05-09 22:29:23 ET Summary Rebalancing your dividend portfolio is essential for long-term investment success. Doing so helps to maintain a consistently reduced risk level, thereby improving the likelihood of positive investment outcomes. In today's article, I will analyze the ...
2024-05-09 18:44:45 ET More on Catalyst Pharmaceuticals, Sarepta Therapeutics, etc. Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alter...
2024-05-09 08:15:00 ET Dividends may be boring but are essential to building a well-balanced portfolio. After all, dividend payments have accounted for approximately 85% of the S&P 500 's total returns since 1960, per a report by Hartford Funds. Which dividend stocks are worth b...
2024-05-09 04:37:00 ET After steadily raising its payout by 163% over the past 15 years, Pfizer (NYSE: PFE) continues to be one of the most reliable pharma stocks an income-seeking investor can reach for these days. The company is a pharmaceutical giant with many parts moving in dif...
2024-05-08 10:46:32 ET More on Pfizer Pfizer: A 6% Yield And At 10-Year Lows Pfizer Stock: Not A Value Trap, Here's Why Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet Boy given Pfizer experimental Duchenne muscular dystrophy therapy dies P...
2024-05-08 10:37:16 ET Summary Pfizer's stock has experienced significant fluctuations in the past 4 years, with opportunities for investors to buy low and sell high. The market has driven Pfizer's price to a 10-year low. Pfizer's focus on oncology and its strong pipeline of n...
2024-05-08 08:30:00 ET Summary Pfizer Inc.'s COVID vaccine revenue plunged to $354M in Q1, indicating a dramatic reset. It should help Pfizer potentially outperform moving ahead as it laps easier comps. Pfizer is a fundamentally strong stock with a dividend yield of almost 6%....
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...
2024-07-24 10:08:31 ET DENVER, Colo., Jul 24, 2024 ( 247marketnews.com )- Sangamo Therapeutics, Inc. (Nasdaq: SGMO ) expounded on Pfizer’s (NYSE: PFE ) positive topline results from their Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an invest...
2024-07-24 09:00:21 ET Pfizer Inc. (PFE) declaring a stock dividend of $0.42 per share on Ex-Date : July 25, 2024. Shareholders on record as of July 26, 2024 are eligible for the dividend. The payment date is scheduled for September 03, 2024, and the declaration was officially made ...